Dr Reddy's Labs, DNDi ink pact to develop affordable drugs for neglected tropical diseases Ruchika Sharma1 Sept 2022 3:41 PM ISTNew Delhi: Dr. Reddy's Laboratories Ltd. and Aurigene Pharmaceutical Services Limited, a contract research, development, and manufacturing services...
Dr Reddy's Labs to acquire Slayback Pharma OTC ophthalmic product rights Ruchika Sharma30 July 2022 4:07 PM ISTSlayback Pharma is the first company to file an ANDA for the private label equivalent for Lumify with the USFDA under Paragraph IV certification.
Dr Reddy's Labs launches Fesoterodine Fumarate Extended-Release Tablets in US Ruchika Sharma9 July 2022 2:55 PM ISTHyderabad: Drugmaker, Dr. Reddy's Laboratories Ltd., has announced the launch of the company's Fesoterodine Fumarate Extended-Release Tablets, a...
USFDA issues 2 observations for Dr Reddy's Labs Srikakulam facility Ruchika Sharma8 July 2022 11:31 AM ISTNew Delhi: Drugmaker, Dr Reddy's Laboratories, has recently announced that the United States Food & Drug Administration (USFDA) has...
Dr Reddys Labs settles patent litigation with Aquestive Therapeutics, Indivior Ruchika Sharma30 Jun 2022 6:15 PM ISTThe said agreement resolves all claims between the parties relating to the company's generic buprenorphine and naloxone sublingual film, 2 mg/0.5 mg,...
JB Pharma acquires 4 pediatric brands from Dr Reddys Ruchika Sharma30 Jun 2022 12:19 PM ISTThe acquisition has been done for a cash consideration of Rs 98.3 crores.
Drug alert: CDSCO flags 41 medicine batches as not of standard quality Susmita Roy11 Jun 2022 6:35 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 41...
Dr Reddys to sell Finast, Styptovit-E and 2 other brands to Torrent Pharma Ruchika Sharma27 May 2022 12:21 PM ISTAs per the terms of the definitive agreement, Torrent Pharma will take over the manufacturing, marketing and distribution of these brands in India.
Medley Pharma up for sale, expected to be sold for Rs 5,000 crore Susmita Roy26 May 2022 11:06 AM ISTNew Delhi: Medley Pharma, a privately held Mumbai-based pharmaceutical company, is up for sale and is expected to be sold for Rs 5,000 crore in a...
Dr Reddys Labs, HK inno.N Corporation ink pact to commercialize Tegoprazan in India, 6 key emerging Markets Ruchika Sharma12 May 2022 12:19 PM ISTThe agreement grants Dr. Reddy's the exclusive rights to develop and commercialise Tegoprazan under its own trademark in these markets for 10 years...
Ex Dr Reddys President Saumen Chakraborty joins Premas Biotech Board of Directors Ruchika Sharma10 May 2022 11:30 AM ISTSaumen Chakraborty retired as the President and Chief Financial Officer of Dr Reddy’s in 2020 and served as an Advisor to them for the next year.
Dr Reddys gets USFDA EIR for Duvvada facilities Ruchika Sharma21 Feb 2022 3:37 PM ISTHyderabad: Pharma major, Dr Reddy's Labs, today announced that the company has received the Establishment Inspection Report (EIR) from the U.S...
